La description
[Drug name]
Generic name: Combined Clostridium Butyricum and Bifidobacterium
Powders, Live
Brand name: Clobico
[Ingredients]Â Â Â
Active ingredient: Clostridium butyricum, Bifidobacterium
infantis
Inactive ingredient: Corn starch, Anhydrous glucose
[Character]
This product shall be white or grayish white powder.
[Indications]
Indicated for intestinal flora imbalance and related acute and
chronic diarrhea and dyspepsia.
[Specification]
**0mg /Â sachet (within the shelf life, each sachet contains
clostridium butyricum with the viable count of not less than 1.***7
CFU/g and bifidobacterium infantis with the viable count of not
less than 1.***6 CFU/g)
[Usage and dosage]
Oral administration, 3 sachets a time, twice a day.
For acute diarrhea, continuously use for 3~7 days; for chronic
diarrhea, continuously use for *4~*1 days.
Â
[Side effects]
The Phase IÂ ~ III of Clinical trial have showed that
a few patients slightly developed skin rash and stomach
upset.
[Contraindications]
Not to be taken by those who are allergic to probiotics.
[Announcements]
Not to be taken with hot water.
[Medication for pregnant women and lactation female]
It can be taken by the pregnant women and lactation female.
Â
[Medication for children]
Oral administration, 1 sachet a time, twice a day.
It can be taken with cold boiled water, juice and milk.
[Drug interaction]
Not to be taken with antibiotics at the same time.
[Drug overdose]Â
This product is probiotics. No overdose is reported.
[Pharmacology& Toxicology]
The pharmacodynamics test in mice showed that this product can stop
diarrhea caused by ampicillin. Clostridium butyricum can inhibit
the growth of intestinal pathogenic bacteria such as el tor vibrio
cholerae *1 group, vibrio cholerae ***9, escherichia coli ***7,
etc. This product can also inhibit the growth of shigella dysentery
and salmonella porcine cholera.
[Pharmacokinetics]
Clostridium butyricum can be colonized temporarily in the
intestinal tract and kept for about ten days before being
eliminated from the body. Bifidobacterium infantis is
a resident beneficial bacterium, which can be colonized and
grown in the intestinal tract after oral administration.
[Storage]Â Â
Store at 2~8 ºC and protect from light.
[Package]
Packing material: medicinal composite membrane
Packing specification: **0mg /Â sachet, *0 sachets
/Â box
[Shelf life]
*4 months     Â
[Manufacturing enterprise]
Manufacturer: Shandong Kexing Bioproducts Co., Ltd.
Manufacturing site: No. ***6 Chuangye Road, Mingshui Development
Zone, Zhangqiu, Shandong, China
| Pays: |
China |
| N ° de modèle: |
-
|
| Prix FOB: |
(Negotiable)
Obtenir le dernier prix
|
| Localité: |
- |
| Prix de commande minimale: |
- |
| Commande minimale: |
- |
| Packaging Detail: |
- |
| Heure de livraison: |
- |
| Capacité de Fournir: |
- |
| Payment Type: |
- |
| Groupe de produits : |
- |
